CVS Health CorporationCVSNYSE
Loading

Analyst Sentiment

Analysts lean bullish — 92% recommend buying.

Consensus Rating
Buy
25 analysts·High coverage
92%
Rating Distribution
Strong Buy
00%
Buy
2392%
Hold
28%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 18% higher.

Bear Case
$90.00
+12%
Consensus
$94.92
+18%
Bull Case
$103.00
+28%
Price Range25 analysts
Low
Consensus
High
$90.00
$103.00
Current Target
Current Price
$80.49
Upside to Target
$14.43

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$7.17(18 analysts)
P/E58x
Current: 57.8x
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev+5.00%
EPS+14.21%
FY2028
Rev+5.35%
EPS+15.33%
FY2029
Rev+5.66%
EPS+10.07%

Earnings Surprises

Beat rate:83%(10/12 quarters)
Avg surprise:+7.5%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 28, 2026Argus Research
CVS Health price target lowered to $90 from $91 at Argus
Target:$90.00
+22.9%from $73.20
Jan 6, 2026Bernstein
CVS Health price target raised to $91 from $87 at Bernstein
Target:$91.00
+13.0%from $80.56
Dec 12, 2025Bernstein
CVS Health price target raised to $87 from $86 at Bernstein
Target:$87.00
+7.6%from $80.84
Dec 10, 2025Mizuho Securities
CVS Health price target raised to $95 from $88 at Mizuho
Target:$95.00
+20.2%from $79.05
Dec 10, 2025Robert W. Baird
CVS Health price target raised to $92 from $82 at Baird
Target:$92.00
+17.6%from $78.24
Dec 10, 2025Piper Sandler
CVS Health price target raised to $101 from $99 at Piper Sandler
Target:$101.00
+29.1%from $78.24
Dec 10, 2025Morgan Stanley
CVS Health price target raised to $93 from $89 at Morgan Stanley
Target:$93.00
+18.9%from $78.24
Dec 10, 2025Barclays
CVS Health price target raised to $93 from $87 at Barclays
Target:$93.00
+18.9%from $78.24
Dec 10, 2025UBS
CVS Health price target raised to $97 from $96 at UBS
Target:$97.00
+24.0%from $78.24
Dec 10, 2025Truist Financial
BofA Securities Reiterates Buy Rating on CVS Health (CVS)
Target:$100.00
+27.8%from $78.24
Dec 4, 2025Bernstein
CVS Health price target raised to $86 from $77 at Bernstein
Target:$86.00
+12.1%from $76.75
Oct 30, 2025RBC Capital
CVS Health price target raised to $93 from $81 at RBC Capital
Target:$93.00
+19.9%from $77.56
Oct 24, 2025UBS
CVS Health price target raised to $96 from $79 at UBS
Target:$96.00
+18.4%from $81.07
Oct 14, 2025Truist Financial
CVS Health price target raised to $92 from $84 at Truist
Target:$92.00
+16.1%from $79.26
Oct 14, 2025Morgan Stanley
CVS Health price target raised to $89 from $82 at Morgan Stanley
Target:$89.00
+12.9%from $78.82
Oct 14, 2025Goldman Sachs
CVS Health initiated with a Buy at Goldman Sachs
Target:$91.00
+16.0%from $78.44
Oct 9, 2025Mizuho Securities
CVS Health price target raised to $88 from $76 at Mizuho
Target:$88.00
+14.4%from $76.93
Oct 7, 2025Wells Fargo
CVS Health price target raised to $103 from $84 at Wells Fargo
Target:$103.00
+34.0%from $76.84
Sep 4, 2025Barclays
CVS Health price target raised to $87 from $80 at Barclays
Target:$87.00
+18.7%from $73.32
Aug 18, 2025UBS
CVS Health upgraded to Buy from Neutral at UBS
Target:$79.00
+15.2%from $68.60
Aug 14, 2025Robert W. Baird
CVS Health upgraded to Outperform from Neutral at Baird
Target:$82.00
+23.2%from $66.58
Jun 2, 2025Barclays
CVS Health price target lowered to $79 from $82 at Barclays
Target:$79.00
+24.2%from $63.60
Feb 18, 2025Argus Research
CVS Health price target raised to $77 from $68 at Argus
Target:$77.00
+17.4%from $65.57
Dec 3, 2024Deutsche Bank
Deutsche Bank Upgrades CVS Health (CVS) to Buy
Target:$66.00
+11.7%from $59.08
Nov 18, 2024Wells Fargo
Wells Fargo Upgrades CVS Health (CVS) to Overweight
Target:$66.00
+15.6%from $57.11